Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Vaccines Office Head Midthun Joins From Analgesic Division

Executive Summary

FDA Office of Vaccines Research & Review Director Karen Midthun, MD, has experience in early development studies of vaccine candidates for HIV, hepatitis A and rotavirus.

You may also be interested in...



FDA Anti-Inflammatory Division Director Will Be Celebrex Investigator Simon

Celebrex clinical investigator Lee Simon, MD, will take over as director of FDA's Division of Anti-Inflammatory, Analgesic & Ophthalmic Drug Products Nov. 19.

FDA Anti-Inflammatory Division Director Will Be Celebrex Investigator Simon

Celebrex clinical investigator Lee Simon, MD, will take over as director of FDA's Division of Anti-Inflammatory, Analgesic & Ophthalmic Drug Products Nov. 19.

FDA Reproductive Division Deputy Is Ditropan XL Reviewer Shames

FDA has named Daniel Shames, MD, as deputy director of its Division of Reproductive & Urologic Drug Products.

Related Content

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel